Abstract:The non-receptor protein tyrosine kinase c-Src regulates diverse biological processes by associating with multiple signaling and structural molecules. Overexpression of c-Src occurs in pancreatic cancer and can be predictive of poor prognosis. The aim of this study was to investigate the inhibitory effects of plasmid-based siRNAs targeting the human c-Src gene on proliferation and angiogenesis in the human pancreatic adenocarcinoma cell line Panc-1. Three siRNAs targeting the c-Src gene were transfected into the Panc-1 pancreatic adenocarcinoma cell line mediated by Lipofectamine. Transfection efficiency was assessed by flow cytometry. Real-time quantitative PCR (RQ-PCR) was employed to detect the expression of c-Src mRNA, and the most effective siRNA was chosen to be cloned into a plasmid. Two single-strand DNA templates were designed according to the most effective siRNA sequences. The short hairpin RNA (shRNA) plasm id targeting c-Src with pGPU6/green fluorescent protein (GFP)/Neo vector psiRNA-c-Src was constructed. Sequencing was performed to check whether the plasmid was constructed correctly. Panc-1 cells were transfected with psiRNA-c-Src and the negative control plasmid (psiRNA-N), respectively. Following selection with G418, the transfected monoclonal cells were chosen. GFP was evaluated by flow cytometry and fluorescence microscopy to estimate transfection efficiency. RQ-PCR and western blotting were used to detect c-Src silencing efficiency. To verify the effects of gemcitabine chemoresistance of c-Src expression, MTT assay was performed. ELISA was used to determine VEGF levels in culture supernatants. In a nude mouse model, tumor growth was studied, c-Src, VEGF expression and microvessel density in tumor tissue were measured by immunohistochemistry. The transfection efficiency of siRNA in the Panc-1 cell line was above 90%, the most effective siRNA could suppress expression of the c-Src gene with an inhibition efficiency of 86.1%. Sequencing confirmed that the c-Src siRNA plasmid was successfully constructed. MTT assay indicated that the effect of gemcitabine-induced cytotoxicity was markedly increased in the psiRNA-c-Src group (P<0.05). Meanwhile, the expression of VEGF in vitro was reduced significantly (P<0.05) in the psiRNA-c-Src group. In nude mice bearing tumors, c-Src, VEGF expression and MVD were decreased in tumors produced from psiRNA-c-Src transfected cells (P<0.05). In summary, the siRNA expression constructs targeting c-Src could specifically suppress c-Src expression, inhibit VEGF expression, inhibit cell proliferation and enhance gemcitabine chemosensitivity in vitro. C-Src gene silencingwas able to inhibit angiogenesis of tumors in vivo. These findings demonstrate that the c-Src targeting gene silencing approach has the potential to serve as a novel tool for pancreatic carcinoma treatment.

Depletion of Insulin Receptor Substrate 2 Reverses Oncogenic Transformation Induced by V-Src

The role of insulin receptor substrate-1 in transformation by v-src.

Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2.

Insulin Receptor Substrate-1 Regulates The Transformed Phenotype Of Bt-20 Human Mammary Cancer Cells

Irs-2, but Not Irs-1, Can Sustain Proliferation and Rescue Ubf Stabilization in Inr or Inr Defective Signaling of 32d Myeloid Cells

Insulin-like Growth Factor I Receptor Signaling and Nuclear Translocation of Insulin Receptor Substrates 1 and 2.

Enhancer RNA IRS2e is Essential for IRS2 Expression and the Oncogenic Properties in Oral Squamous Cell Carcinoma

The Insulin Receptor Adaptor IRS2 is an APC/C Substrate That Promotes Cell Cycle Protein Expression and a Robust Spindle Assembly Checkpoint

Regulation of Insulin Receptor Substrate‐1 Expression Levels by Caveolin‐1

Interaction Between Nuclear Insulin Receptor Substrate-2 and NF-κB in IGF-1 Induces Response in Breast Cancer Cells.

Deletion of the Pleckstrin and Phosphotyrosine Binding Domains of Insulin Receptor Substrate-2 Does Not Impair Its Ability to Regulate Cell Proliferation in Myeloid Cells

MFN2 Provides Antitumor Efficacy in Pancreatic Cancer Cells

Role of IRS-2 in insulin and cytokine signalling

Fluorescent tagging of endogenous IRS2 with an auxin-dependent degron to assess dynamic intracellular localization and function

A Study of the Suppressive Effect on Human Pancreatic Adenocarcinoma Cell Proliferation and Angiogenesis by Stable Plasmid-Based Sirna Silencing of C-Src Gene Expression.

Downregulation Of Irs-1 Promotes Metastasis Of Head And Neck Squamous Cell Carcinoma

Inhibition Of The Rsk2-Atf1 Signaling Axis By Eriodictyol Suppresses Neoplastic Cell Transformation

Silencing IGF-II Impairs C-myc and N-ras Expressions of SMMC-7721 Cells Via Suppressing FAK/PI3K/Akt Signaling Pathway.

Insulin Receptor Substrate-1 and Dishevelled 2 Are Negatively Regulated by Microrna-144 and Inhibit Nasopharyngeal Carcinoma Cell Malignancy.

IRS1 promotes thyroid cancer metastasis through EMT and PI3K/AKT pathways

c-Src regulates cell cycle proteins expression through protein kinase B/glycogen synthase kinase 3 beta and extracellular signal-regulated kinases 1/2 pathways in MCF-7 cells.